Breaking Stories

The Wall Street Journal: FDA, J&J set to announce Baltimore vaccine plant ready to reopen

Panorama of a city business district with office buildings and skyscrapers and superimposed data, charts and diagrams related to stock market, currency exchange and global finance. Blue line graphs with numbers and exchange rates, candlestick charts and financial figures fill the image with a glowing light. Sunset light.

The Food and Drug Administration and vaccine maker Johnson & Johnson expect to announce as early as Friday that contamination problems at a COVID-19 vaccine plant in Baltimore are resolved, clearing the way for millions more doses to become available.

The Wall Street Journal: Google close to settling ad-tech antitrust case in France

Previous article

: Tesla Model 3 loses Consumer Reports’ ‘top pick’ after safety-feature switch

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *